Durham, North Carolina, January 24, 2008 – Vascular BioSciences announced today that it has opened an office in Research Triangle, North Carolina that will be the principal location of the company’s research and development efforts.
The Research Triangle office will be the headquarters for the company’s interventional, molecular diagnostic, and therapeutic research and development pursuits. The company’s
San Diego office will continue to serve as the coordinating facility for West Coast academic and corporate collaborations.
David Mann, CEO and Chairman of Vascular BioSciences, commented, “The Research Triangle area of North Carolina is one of the largest biotechnology hubs in the world and offers numerous opportunities to work closely with many outstanding academic institutions and corporate partners. As research and development is the current principal activity of the company, we look forward to further advancing these efforts through this strategic relocation.”
About Vascular BioSciences
Vascular BioSciences provides solutions for vascular-based diseases in order to enhance and prolong human life.
Vascular BioSciences makes interventional catheters to obtain endoarterial biopsies, provides diagnostic services, and advances therapies in order to improve outcomes for vascular–based disease patients.